James Condulis
Stock Analyst at Stifel
(2.69)
# 2,120
Out of 5,072 analysts
7
Total ratings
66.67%
Success rate
16.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $24 | $9.67 | +148.19% | 1 | Sep 29, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $68.15 | +40.87% | 2 | Sep 2, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $41.45 | +6.15% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $49.55 | +117.96% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $25.52 | +17.55% | 1 | Jan 22, 2025 |
Aardvark Therapeutics
Sep 29, 2025
Initiates: Buy
Price Target: $24
Current: $9.67
Upside: +148.19%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $68.15
Upside: +40.87%
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $41.45
Upside: +6.15%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $49.55
Upside: +117.96%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $25.52
Upside: +17.55%